id: NEW:medication_formulary_availability_to_sud_medication_treatment_rate_oud
name: Availability of Alcohol Dependence Medications in Formulary â†’ SUD Medication Treatment Rate
from_node:
  node_id: NEW:medication_formulary_availability
  node_name: Availability of Alcohol Dependence Medications in Formulary
to_node:
  node_id: sud_medication_treatment_rate_oud
  node_name: SUD Medication Treatment Rate
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Limited number of approved/available medications for alcohol dependence restricts treatment
  options'
- 'Step 2: Different medications work for different patient populations; limited options reduce likelihood
  of finding effective treatment'
- 'Step 3: Availability of substitution therapy options (e.g., GHB in Italy) expands the pool of treatable
  patients'
- 'Step 4: Greater medication variety enables personalized treatment matching and higher overall utilization'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'Roberta Agabio et al. 2021. "Use of Medications for the Treatment of Alcohol Dependence:
    A Retrospective Study Conducted in 2011-2012.." https://doi.org/10.2174/2589977512666201228121820'
  supporting_citations:
  - Additional citations require full-text access - abstract notes 'limited number of available medications'
    as documented barrier
  - Reference to GHB (gamma-hydroxybutyrate) as substitution therapy available in Italian context
  - Comparison with countries having fewer medication options showing lower utilization
  doi: 10.2174/2589977512666201228121820
  citation_verified: true
last_updated: '2025-12-06'
version: '2.0'
description: The range of medications approved and available for alcohol dependence treatment varies by
  jurisdiction. Greater medication availability, including substitution therapies like GHB, enables higher
  treatment rates.
quantitative_effects:
  effect_size:
    value: 34.3
    type: percentage_change
  sample_size: 345
spatial_variation:
  varies_by_geography: true
  variation_notes: Italy has GHB available as substitution therapy, which is not available in many other
    countries; 34.3% of patients used GHB
moderators:
- name: medication_regulatory_approval
  direction: strengthens
  strength: strong
  description: Regulatory decisions about which medications are approved and available directly determine
    treatment options
structural_competency:
  equity_implications: Medication availability is determined by regulatory policy and healthcare system
    decisions, not individual choices. This mechanism shows how pharmaceutical policy directly shapes
    treatment access and outcomes.
llm_metadata:
  extracted_by: claude-opus-4-5-20251101
  extraction_date: '2025-12-06T21:12:37.260168'
  extraction_confidence: medium
  prompt_version: 2.1-canonical-validated
